Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoidsKadi Lõhmussaar(Novo Nordisk Foundation), Hans Clevers(Hubrecht Institute for Developmental Biology and Stem Cell Research)Nature CommunicationsMay 27, 202010.1038/s41467-020-16432-0Cited by 120SaveCiteExport RISWatch citationsRelated PapersProspective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients|Cell|2015|2.4kOrganoid Models of Human and Mouse Ductal Pancreatic Cancer|Cell|2014|2.2kThe β-Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer Cells|Cell|2002|2kLong-Term Culture of Genome-Stable Bipotent Stem Cells from Adult Human Liver|Cell|2014|1.6kIn vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration|Nature|2013|1.6k